What is the recommended starting dose of Depakote ER (divalproex sodium extended‑release)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Dose for Depakote ER

The recommended starting dose of Depakote ER is 500 mg once daily for 1 week, then increase to 1000 mg daily for migraine prophylaxis 1.

Indication-Specific Dosing

The starting dose varies significantly based on the indication:

For Migraine Prophylaxis

  • Start: 500 mg once daily for 1 week
  • Maintenance: Increase to 1000 mg daily 1
  • This is the most conservative starting approach among all indications

For Acute Mania (Bipolar Disorder)

  • Start: 25 mg/kg/day once daily 1
  • Increase as rapidly as possible to achieve therapeutic response
  • Target plasma concentration: 85-125 mcg/mL
  • Maximum: 60 mg/kg/day 1

For Epilepsy (Complex Partial Seizures)

  • Monotherapy: Start at 10-15 mg/kg/day 1
  • Increase by 5-10 mg/kg/week to achieve optimal response
  • Target plasma concentration: 50-100 mcg/mL
  • Maximum: 60 mg/kg/day 1

For Absence Seizures

  • Start: 15 mg/kg/day 1
  • Increase at 1-week intervals by 5-10 mg/kg/day
  • Maximum: 60 mg/kg/day

Critical Administration Details

Depakote ER must be swallowed whole and should not be crushed or chewed 1. This is essential because crushing destroys the extended-release mechanism, potentially causing:

  • Gastric irritation and side effects
  • Unpredictable drug absorption
  • Serum level fluctuations 2

Important Clinical Considerations

For behavioral/agitation management in Alzheimer's disease (off-label use), older guidelines suggested starting divalproex sodium (regular formulation, not ER) at 125 mg twice daily, titrating to therapeutic blood levels of 40-90 mcg/mL 3. However, more recent evidence shows valproate did not prevent agitation in Alzheimer's disease and was associated with significant adverse effects including brain volume loss 4, so this use should be avoided.

Rapid loading strategies exist for acute mania: 30 mg/kg/day has been used safely in inpatient settings to achieve therapeutic levels within 3 days 5, 6, but this is an aggressive approach requiring close monitoring.

Monitoring Requirements

Regardless of indication, monitor:

  • Liver enzyme levels regularly
  • Platelets, PT/PTT as indicated 3
  • Therapeutic drug levels (timing depends on indication)
  • Thrombocytopenia risk increases significantly at trough levels >110 mcg/mL (females) or >135 mcg/mL (males) 1

Related Questions

What dose of Depakote (divalproex sodium) should be started?
Can Depakote ER (divalproex sodium) 2000 mg be prescribed as a single nightly dose?
What is the maximum daily dose of Depakote DR (delayed‑release divalproex sodium)?
What are the dosing guidelines and contraindications for Depakote (divalproex sodium), and can it be taken with or without food?
What are the implications of reducing the dose of divalproex (valproic acid) extended release (ER) from 250mg to 125mg delayed release (DR) in an adult patient with bipolar disorder experiencing side effects such as cognitive changes and irritable bowel syndrome?
What is the recommended protocol for using medical‑grade honey and calcium alginate dressings to treat a clean, non‑infected heel pressure ulcer with moderate exudate?
What is the appropriate management for obesity hypoventilation syndrome?
Could a 45-year-old obese male, 2 weeks post percutaneous transluminal coronary angioplasty (PTCA) of the left anterior descending artery, presenting with severe hypertension, tachycardia, exertional shortness of breath that improves with non‑invasive ventilation, normal arterial blood gases at rest, preserved left‑ventricular ejection fraction, no peripheral edema, and normal renal function, be diagnosed with obesity‑hypoventilation syndrome?
What does a curvilinear lucency with sclerotic margins at the lateral aspect of the tip of the first distal phalanx on a foot X‑ray indicate—vascular channel or undisplaced fracture?
What tests should be ordered for a comprehensive sexually transmitted infection (STI) screen?
For a 200‑lb (≈91 kg) patient, what starting dose of Depakote ER (valproic acid extended‑release) should be used?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.